Literature DB >> 25201202

Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ).

Vijay Menon1, Lawrence Povirk.   

Abstract

p53 is a tumor suppressor protein that prevents oncogenic transformation and maintains genomic stability by blocking proliferation of cells harboring unrepaired or misrepaired DNA. A wide range of genotoxic stresses such as DNA damaging anti-cancer drugs and ionizing radiation promote nuclear accumulation of p53 and trigger its ability to activate or repress a number of downstream target genes involved in various signaling pathways. This cascade leads to the activation of multiple cell cycle checkpoints and subsequent cell cycle arrest, allowing the cells to either repair the DNA or undergo apoptosis, depending on the intensity of DNA damage. In addition, p53 has many transcription-independent functions, including modulatory roles in DNA repair and recombination. This chapter will focus on the role of p53 in regulating or influencing the repair of DNA double-strand breaks that mainly includes homologous recombination repair (HRR) and non-homologous end joining (NHEJ). Through this discussion, we will try to establish that p53 acts as an important linchpin between upstream DNA damage signaling cues and downstream cellular events that include repair, recombination, and apoptosis.

Entities:  

Mesh:

Year:  2014        PMID: 25201202      PMCID: PMC4235614          DOI: 10.1007/978-94-017-9211-0_17

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  100 in total

1.  Analysis of the binding of p53 to DNAs containing mismatched and bulged bases.

Authors:  N Degtyareva; D Subramanian; J D Griffith
Journal:  J Biol Chem       Date:  2000-12-20       Impact factor: 5.157

Review 2.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

3.  A novel function of Rad54 protein. Stabilization of the Rad51 nucleoprotein filament.

Authors:  Alexander V Mazin; Andrei A Alexeev; Stephen C Kowalczykowski
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

4.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

5.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.

Authors:  S Matsuoka; G Rotman; A Ogawa; Y Shiloh; K Tamai; S J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 6.  Functions of the MDM2 oncoprotein.

Authors:  D A Freedman; L Wu; A J Levine
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

Review 7.  Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging.

Authors:  Dharmendra Kumar Singh; Byungchan Ahn; Vilhelm A Bohr
Journal:  Biogerontology       Date:  2008-12-15       Impact factor: 4.277

8.  A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

Authors:  Y Gao; Y Sun; K M Frank; P Dikkes; Y Fujiwara; K J Seidl; J M Sekiguchi; G A Rathbun; W Swat; J Wang; R T Bronson; B A Malynn; M Bryans; C Zhu; J Chaudhuri; L Davidson; R Ferrini; T Stamato; S H Orkin; M E Greenberg; F W Alt
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein.

Authors:  H Lu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair.

Authors:  Gisa S Boehden; Nuray Akyüz; Klaus Roemer; Lisa Wiesmüller
Journal:  Oncogene       Date:  2003-06-26       Impact factor: 9.867

View more
  25 in total

Review 1.  DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

Authors:  Altan Kara; Aykut Özgür; Sinem Nalbantoğlu; Abdullah Karadağ
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

Review 2.  Identifying therapeutic targets in gastric cancer: the current status and future direction.

Authors:  Beiqin Yu; Jingwu Xie
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-15       Impact factor: 3.848

3.  Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.

Authors:  Rebecca A Frum; Ian M Love; Priyadarshan K Damle; Nitai D Mukhopadhyay; Swati Palit Deb; Sumitra Deb; Steven R Grossman
Journal:  Mol Cancer Res       Date:  2016-03-10       Impact factor: 5.852

Review 4.  The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.

Authors:  Zahra Torki; Davood Ghavi; Solmaz Hashemi; Yazdan Rahmati; Dara Rahmanpour; Majid Pornour; Mohammad Reza Alivand
Journal:  Cancer Chemother Pharmacol       Date:  2021-09-12       Impact factor: 3.333

5.  Replication-dependent cytotoxicity and Spartan-mediated repair of trapped PARP1-DNA complexes.

Authors:  Liton Kumar Saha; Yasuhisa Murai; Sourav Saha; Ukhyun Jo; Masataka Tsuda; Shunichi Takeda; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

6.  Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.

Authors:  Julian Scheper; Laura S Hildebrand; Eva-Maria Faulhaber; Lisa Deloch; Udo S Gaipl; Julia Symank; Rainer Fietkau; Luitpold V Distel; Markus Hecht; Tina Jost
Journal:  Strahlenther Onkol       Date:  2022-10-13       Impact factor: 4.033

7.  A pan-cancer compendium of chromosomal instability.

Authors:  Geoff Macintyre; Florian Markowetz; Ruben M Drews; Barbara Hernando; Maxime Tarabichi; Kerstin Haase; Tom Lesluyes; Philip S Smith; Lena Morrill Gavarró; Dominique-Laurent Couturier; Lydia Liu; Michael Schneider; James D Brenton; Peter Van Loo
Journal:  Nature       Date:  2022-06-15       Impact factor: 69.504

8.  KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis.

Authors:  Amr M Ghaleb; Enas A Elkarim; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Mol Cancer Res       Date:  2016-02-02       Impact factor: 5.852

9.  Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.

Authors:  Calixto-Hope G Lucas; Harish N Vasudevan; William C Chen; Stephen T Magill; Steve E Braunstein; Line Jacques; Sonika Dahiya; Fausto J Rodriguez; Andrew E Horvai; Arie Perry; Melike Pekmezci; David R Raleigh
Journal:  Neurooncol Adv       Date:  2020-10-01

10.  Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.

Authors:  Brenen W Papenberg; James Ingles; Si Gao; Jun Feng; Jessica L Allen; Steven M Markwell; Erik T Interval; Phillip A Montague; Sijin Wen; Scott A Weed
Journal:  Cancer Genet       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.